Regression of Melanoma in a Murine Model by RLIP76 Depletion
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
RLIP76/RALBP1 is a stress-responsive membrane protein implicated in the regulation of multiple cellular signaling pathways. It represents the predominant glutathione-conjugate transporter in cells, and our previous studies have shown that its inhibition by antibodies or depletion by short interfering RNA (siRNA) causes apoptosis in a number of cancer cell types. The present studies were done to explore the potential clinical applicability of our previous observations by comparing the relative expression of RLIP76 in cancer versus normal cell lines and to determine whether depletion of RLIP76 activity can exert cancer-specific apoptosis. RLIP76 expression was found to be significantly greater in malignant cells compared to nonmalignant cells. Inhibition of RLIP76, using antibodies towards a cell surface epitope, or depletion of RLIP76 using either siRNA or antisense phosphorothioate oligonucleotides preferentially caused apoptosis in malignant cells. More importantly, in vivo studies showed that administration of RLIP76 antibodies, siRNA, or antisense oligonucleotides to mice bearing syngeneic B16 mouse melanoma cells caused complete tumor regression within 10 days. These findings strongly suggest that RLIP76 depletion by genetic approaches or inhibition by antibodies may be a clinically viable antineoplastic therapy, particularly for melanoma. (Cancer Res 2006; 66(4): 2354-60)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bridging Ral GTPase to Rho Pathways
Jullien-Flores, V., Dorseuil, O., Romero, F., Letourneur, F., Saragosti, S., Berger, R., Tavitian, A., Gacon, G., & Camonis, J. H. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.38.22473 · Cited by 338
Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptors
Nakashima, S., Morinaka, K., Koyama, S., Ikeda, M., Kishida, M., Okawa, K., Iwamatsu, A., Kishida, S., & Kikuchi, A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3629 · Cited by 231
Cheng, J.-Z., Sharma, R., Yang, Y., Singhal, S. S., Sharma, A., Saini, M. K., Singh, S. V., Zimniak, P., Awasthi, S., & Awasthi, Y. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106838200 · Cited by 185 · cited 1×
“These animal studies, as well as several studies by us and others in cell culture systems, have implicated RLIP76 as a part of stress defenses (22, 23), as well as a modulator of signaling through Ras, Ral (11), cdc-2 (19), cdc-42 (11), heat-shock proteins (24), EGF, TGF, and insulin (12, 18–21).”
BackgroundSelf-citationNovel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin
Awasthi, S., Cheng, J., Singhal, S. S., Saini, M. K., Pandya, U., Pikula, S., Bandorowicz-Pikula, J., Singh, S. V., Zimniak, P., & Awasthi, Y. C. (2000) · Biochemistry · doi:10.1021/bi992964c · Cited by 159
Self-citationAn Eps Homology (EH) Domain Protein That Binds to the Ral-GTPase Target, RalBP1
Yamaguchi, A., Urano, T., Goi, T., & Feig, L. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31230 · Cited by 126
Awasthi, S., Singhal, S. S., Sharma, R., Zimniak, P., & Awasthi, Y. C. (2003) · International Journal of Cancer · doi:10.1002/ijc.11260 · Cited by 120
Self-citationHu, Y., & Mivechi, N. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300788200 · Cited by 101 · cited 1×
“These animal studies, as well as several studies by us and others in cell culture systems, have implicated RLIP76 as a part of stress defenses (22, 23), as well as a modulator of signaling through Ras, Ral (11), cdc-2 (19), cdc-42 (11), heat-shock proteins (24), EGF, TGF, and insulin (12, 18–21).”
BackgroundRLIP76 is a major determinant of radiation sensitivity
Awasthi, S., Singhal, S. S., Yadav, S., Singhal, J., Drake, K., Nadkar, A., Zajac, E., Wickramarachchi, D., Rowe, N., Yacoub, A., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0968 · Cited by 88 · cited 3×
“Because RLIP76 represents the major transporter of doxorubicin as well as DNP-SG, as observed both in cell line studies (29) and in knockout mice (17), we examined whether the content of RLIP76 Figure 1.”
BackgroundSelf-citation
Cited by
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment
Chikara, S., Nagaprashantha, L. D., Singhal, J., Horne, D., Awasthi, S., & Singhal, S. S. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.002 · Cited by 559
Self-citationChemistry and biochemistry of lipid peroxidation products
Guéraud, F., Atalay, M., Bresgen, N., Cipak, A., Eckl, P. M., Huc, L., Jouanin, I., Siems, W., & Uchida, K. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498477 · Cited by 552
Pathological aspects of lipid peroxidation
Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., et al. (2010) · Free Radical Research · doi:10.3109/10715762.2010.498478 · Cited by 449
RalBP1 is necessary for metastasis of human cancer cell lines
Wu, Z., Owens, C., Chandra, N., Popovic, K., Conaway, M., & Theodorescu, D. (2010) · Neoplasia · doi:10.1593/neo.101080 · Cited by 70
“Depletion of RalBP1 by antisense or inhibition of its function by antibody decreased subcutaneous xenograft tumor growth in a number of cancer cell lines [8,9].”
Background
Metadata
- Authors
- Singhal, S. S., Awasthi, Y. C., & Awasthi, S.
- Venue
- Cancer Research
- Published
- 2006-02-15
- Volume
- 66
- Issue
- 4
- Pages
- 2354-2360
- ISSN
- 0008-5472 (ISSN-L)
- 1538-7445
- OpenAlex
- W2073400076
- Cited by
- 102
- References
- 8
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Regression of Melanoma in a Murine Model by RLIP76 Depletion. https://app.cochat.ai/papers/10.1158/0008-5472.can-05-3534
- The paper
- Singhal, S. S., Awasthi, Y. C., & Awasthi, S. (2006). Regression of Melanoma in a Murine Model by RLIP76 Depletion. Cancer Research. https://doi.org/10.1158/0008-5472.can-05-3534
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.